Table 2.

Pathways of candidate lncRNAs target mRNAs with the largest significant difference in KEGG analysis

Pathway	Fisher-P value	Top enriched genes
Wnt signaling pathway	0.000210417	BTRC,CAMK2B,CAMK2D,CCND3,CHD8,CREBBP,CSNK2B,CTBP1,CTBP2,CTNNB1,CTNNBIP1,DAAM1,FBXW11,FRAT1,FZD8,FZD9,GSK3B,LEF1,MAPK8,MYC
Pathways in cancer	0.00089539	AGTR1B,ARHGEF1,ARNT,ARNT2,BAK1,BAX,BCL2,BCL2L11,BIRC7,BMP4,BRCA2,CALM4,CAMK2B,CAMK2D,CASP8,CASP9,CCDC6,CCNA1,CCND3,CDKN1A
Thyroid cancer	0.00277648	BAK1,BAX,CCDC6,CDKN1A,CTNNB1,GADD45A,GADD45B,HRAS,LEF1,MYC,RET,TCF7,TCF7L1,TPR,TRP53
Basal cell carcinoma	0.003190856	BAK1,BAX,BMP4,CDKN1A,CTNNB1,FZD8,FZD9,GADD45A,GADD45B,GLI2,GLI3,GSK3B,LEF1,TCF7,TCF7L1,TRP53,WNT10A,WNT11,WNT5A,WNT5B
Endometrial cancer	0.005658717	BAK1,BAX,CASP9,CDKN1A,CTNNB1,ELK1,GADD45A,GADD45B,GSK3B,HRAS,LEF1,MLH1,MYC,PIK3R2,PIK3R3,PTEN,SOS2,TCF7,TCF7L1,TRP53
MAPK signaling pathway	0.007583797	ARRB2,BDNF,CACNA1A,CACNA1F,CACNA1S,CACNA2D1,CACNB3,CACNB4,CACNG1,CDC25B,CHUK,CSF1R,DUSP10,DUSP2,DUSP4,DUSP6,DUSP8,ELK1,EPHA2,FGF2
Phosphatidylinositol signaling system	0.008641106	CALM4,CDS2,DGKG,DGKQ,INPP4A,INPP5A,INPP5E,INPPL1,IP6K3,IPMK,ITPKA,MTMR14,MTMR2,OCRL,PI4K2A,PI4KB,PIK3C3,PIK3R2,PIK3R3,PIKFYVE
Glutamatergic synapse	0.00926066	CACNA1A,DLG4,DLGAP1,GNAO1,GNAQ,GNAS,GNB3,GNB4,GNB5,GNG10,GNG11,GNG4,GNG8,GRIA4,GRIN1,GRM1,GRM7,GRM8,HOMER2,KCNJ3
Breast cancer	0.009525387	BAK1,BAX,BRCA2,CDKN1A,CTNNB1,E2F1,E2F3,FGF2,FGF22,FGF23,FGF6,FGF9,FRAT1,FZD8,FZD9,GADD45A,GADD45B,GSK3B,HRAS,IGF1
Gastric cancer	0.01354918	ABCB1A,BAK1,BAX,BCL2,CDH17,CDKN1A,CTNNB1,E2F1,E2F3,FGF2,FGF22,FGF23,FGF6,FGF9,FGFR2,FRAT1,FZD8,FZD9,GADD45A,GADD45B